HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of calcium electroporation on tumour vasculature.

Abstract
Calcium electroporation (CaEP) is a novel anti-tumour treatment that induces cell death by internalization of large quantities of calcium. The anti-tumour effectiveness of CaEP has been demonstrated in vitro, in vivo, and in preliminary clinical trials; however, its effects on the vasculature have not been previously investigated. Using a dorsal window chamber tumour model, we observed that CaEP affected to the same degree normal and tumour blood vessels in vivo, as it disrupted the vessels and caused tumour eradication by necrosis. In all cases, the effect was more pronounced in small vessels, similar to electrochemotherapy (ECT) with bleomycin. In vitro studies in four different cell lines (the B16F1 melanoma, HUVEC endothelial, FADU squamous cell carcinoma, and CHO cell lines) confirmed that CaEP causes necrosis associated with acute and severe ATP depletion, a picture different from bleomycin with electroporation. Furthermore, CaEP considerably inhibited cell migratory capabilities of endothelial cells and their potential to form capillary-like structures. The finding that CaEP has anti-vascular effects and inhibits cell migration capabilities may contribute to the explanation of the high efficacy observed in preclinical and clinical studies.
AuthorsBarbara Staresinic, Tanja Jesenko, Urska Kamensek, Stine Krog Frandsen, Gregor Sersa, Julie Gehl, Maja Cemazar
JournalScientific reports (Sci Rep) Vol. 8 Issue 1 Pg. 9412 (06 20 2018) ISSN: 2045-2322 [Electronic] England
PMID29925935 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Bleomycin
  • Calcium
Topics
  • Animals
  • Bleomycin (administration & dosage, therapeutic use)
  • CHO Cells
  • Calcium (metabolism)
  • Cell Line, Tumor
  • Cell Movement (drug effects)
  • Cricetulus
  • Electrochemotherapy (methods)
  • Electroporation (methods)
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Neoplasms (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: